logo
China shoppers swap luxury for pre-loved

China shoppers swap luxury for pre-loved

Express Tribune21 hours ago

Chinese energy sector worker Mandy Li likes to treat herself to a luxury brand handbag once in a while. But since her state-owned employer cut her wage by 10 per cent and the properties her family owns lost half their value, she only buys second-hand ones.
"I'm cutting down on large expenditures. The economy is definitely in a downturn," said 28-year-old Li, adding her family's wealth has shrunk due to the property crisis in China since 2021.
As deflationary pressures mount in the world's second-largest economy, consumer behaviour is changing in ways that could lead to further downward pressure on prices, raising concerns that deflation could become entrenched, posing more headaches for China's policymakers.
Data showed on Monday that consumer prices fell 0.1 per cent in May from a year earlier, with price wars raging in a number of sectors, from autos to e-commerce to coffee amid concerns about oversupply and sluggish household demand.
New businesses are seeking success by targeting penny-pinchers. But this trend is worrying economists who see price wars as ultimately unsustainable as losing firms may have to close and people may lose their jobs, fuelling further deflation.
Consumer price sensitivities have accelerated growth in the Chinese second-hand luxury market since the pandemic, with annual growth rates surpassing 20% in 2023, according to an industry report by Zhiyan Consulting from last year.
But that growth has also led to a spike in the volumes of such items, which is noticeable in the level of discounts on offer – up to 90 per cent.
"In the current economic environment we are seeing more existing luxury consumers shifting to the second-hand market," said Lisa Zhang, an expert with Daxue Consulting, a market research and strategy firm focusing on China.
"The middle class – their salary has really decreased. The economy is the number one reason we're seeing these trends."

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Russian rouble gains as oil prices jump on Middle East tensions
Russian rouble gains as oil prices jump on Middle East tensions

Business Recorder

time8 hours ago

  • Business Recorder

Russian rouble gains as oil prices jump on Middle East tensions

The rouble gained against the dollar on Friday, supported by a sharp jump in prices for oil, Russia's main export, after Israel launched major strikes against Iran. Israel said it had attacked nuclear facilities and missile factories and killed a swathe of military commanders in what could be a prolonged operation to prevent Tehran building an atomic weapon. The attacks sparked Iranian retaliation and raised concerns about possible disruption to oil supplies. Brent crude was up 7.9% at $74.83 a barrel by 1124 GMT. The rouble was 0.6% higher at 79.50 per U.S. dollar, according to LSEG data based on over-the-counter quotes. Trading was light, as Russia was marking a two-day national holiday. The rouble appreciated more sharply earlier in the session, but as oil prices pared some of their early gains, so too did the Russian currency. The rouble has strengthened by over 40% against the dollar this year, a rise analysts have attributed to the easing of geopolitical tensions - mainly with U.S. President Donald Trump's administration - and the central bank's tight monetary policy, which has reduced demand for foreign currency. Against the Chinese yuan, the most traded foreign currency in Russia, the rouble strengthened by 0.3% to 10.92 on the Moscow Stock Exchange. The central bank uses yuan for foreign exchange interventions.

AstraZeneca signs AI research deal with China's CSPC for chronic diseases
AstraZeneca signs AI research deal with China's CSPC for chronic diseases

Business Recorder

time8 hours ago

  • Business Recorder

AstraZeneca signs AI research deal with China's CSPC for chronic diseases

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which would help the Anglo-Swedish drugmaker develop therapies for chronic conditions, it said on Friday. The deal marks the latest effort by AstraZeneca to revive its business in China, its second-biggest market, where it has faced several challenges including the arrest of its China president last year and potential fines related to imports. Under Friday's agreement, the two companies will collaborate to discover and develop pre-clinical candidates, including a small molecule oral therapy for immunological diseases, with CSPC conducting AI-driven research in Shijiazhuang City. 'This strategic research collaboration underscores our commitment to innovation to tackle chronic diseases which impact over two billion people globally,' AstraZeneca executive Sharon Barr said in a statement. Friday's agreement follows AstraZeneca's announcement in March that it will invest $2.5 billion in a R&D hub in Beijing, and it also marks further investment in AI following collaborations with Immunai, and Tempus AI. AstraZeneca will pay CSPC an upfront fee of $110 million. The Hong Kong-listed firm is also eligible to receive up to $1.62 billion for reaching development milestones and $3.6 billion linked to sales-related milestones, the groups said in separate statements. They signed a licensing deal last October in which AstraZeneca agreed to pay up to $1.92 billion to CSPC to develop a candidate which would boost its cardiovascular pipeline. AstraZeneca and CSPC both have wide-ranging pipeline portfolios, including cancer treatments and those targeting cardiovascular diseases. However, about 80% of CSPC's total revenue comes from its finished drug segment, according Morningstar analysts. The Chinese group said last month it was in negotiations with third parties on new licensing and collaboration. Friday's agreement also gives AstraZeneca the rights to exercise options for exclusive licenses for candidates identified as part of the collaboration.

India, China agree to expedite resumption of direct flights as ties improve
India, China agree to expedite resumption of direct flights as ties improve

Business Recorder

time9 hours ago

  • Business Recorder

India, China agree to expedite resumption of direct flights as ties improve

India and China have agreed to expedite the resumption of direct air services and step up communication, the two countries' foreign ministries said on Friday, as Beijing and New Delhi continue to mend bilateral ties. The ministries' statements came after a meeting on Thursday of Indian Foreign Secretary Vikram Misri and Chinese Vice Foreign Minister Sun Weidong, who is visiting India. The two countries reached an agreement in October regarding patrolling along their Himalayan border, thawing a standoff that began in 2020 and had strained bilateral ties, impacting areas from trade to technology to air travel. China expresses concern, offers help to resolve Pakistan, India conflict Sun said in the meeting that the two sides should properly handle disputes and differences, and jointly play a constructive role in maintaining international and regional peace and stability, according to the Chinese ministry's statement. The two sides agreed to continue to stabilise and rebuild ties, the Indian ministry's statement said. In January, the neighbours agreed to work on resolving trade and economic differences, a move expected to boost their aviation sectors.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store